JAJohn Adeyemo Adedeji

John Adeyemo Adedeji

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


John Adeyemo Adedeji has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 17 November 2026
    • Published by MDPI AG in Preprints.org
      • https://doi.org/10.20944/preprints202611.1725.v1
    Open Access

    Evidence-Tiering of Culturally Sensitive Vaccine Confidence Interventions in Nigeria

    by Thompson Olusola Oshewa, John Adeyemo Adedeji

    Vaccine hesitancy remains a substantial barrier to immunisation coverage in Nigeria, with a documented historical dimension rooted in the 1996 Trovan trial and its continuing influence on subsequent vaccine campaigns. Programme designers have increasingly turned to culturally embedded intervention models combining trusted local messengers, digital outreach, and narrative-based messaging, but these mechanisms are not equally supported by outcome evidence. This article reviews Nigeria-specific evidence for five recurrent mechanisms identified in programme proposals and grey literature. Two, trusted-messenger engagement and structured digital campaigns, have trial-level support, including a cluster-randomised controlled trial showing substantially higher vaccination odds and a nationally randomised social media evaluation showing measurable reductions in hesitancy. Two others, AI-driven sentiment monitoring and folklore-embedded messaging, remain commonly proposed but empirically untested. We argue that proposal review processes should explicitly grade mechanisms by evidentiary strength, anchoring core design in trial-supported approaches while treating less-evidenced components as piloted, measured additions.

  • Open Access

    Benign Prostatic Hyperplasia in Southwest Nigeria: A Data Gap at the Heart of Routine Urological Practice

    by Cosmas Udochukwu Emele, John Adeyemo Adedeji

    Benign prostatic hyperplasia (BPH) is a histological diagnosis defined by unregulated proliferation of connective tissue, smooth muscle, and glandular epithelium within the prostate gland

  • Open Access

    From Hansch to Diffusion Models: Data, Algorithms, and the Uneven Progress of Computational Drug Discovery

    by John Adeyemo Adedeji

    Computational drug discovery is often narrated as a series of revolutions, each new architecture rendering the last obsolete. This review instead reads six decades of the field, from Hansch and Fujita's 1964 QSAR framework to current diffusion and foundation models, as a single methodological lineage in which later tools extend and absorb earlier ones rather than replace them outright. Five major methodological transitions are examined against the relationship between data availability and method adoption, yielding a specific pattern rather than a general orientation: three transitions, the rise of structure-based design, the shift to broadly applicable machine-learning QSAR, and the current wave of structure-conditioned generative methods, were gated by prior or concurrent expansion of data infrastructure (the Protein Data Bank, ChEMBL, and the AlphaFold Database respectively), while two, the shift from linear regression to non-linear ensemble methods and the 2012 deep learning inflection, were driven primarily by architectural innovation with data availability playing a secondary role. Antimicrobial resistance is used throughout as a stress test, since its combination of target novelty, data sparsity, and evolving resistance mechanisms exposes where each generation of methods has, and has not, generalised, and two documented successes, halicin and abaucin, are examined in detail alongside the downstream synthetic and toxicological attrition that followed their identification. Data debt, meaning unrepresentative, sparse, and inequitably distributed training data, particularly for infectious disease and low-resource contexts, emerges as a persistent constraint that architectural progress alone has not resolved. Seven open problems are identified, most concerning data, validation, and governance rather than model design, and a specific, testable comparison is proposed by which the relative contribution of data scale versus architectural advance could be assessed directly using existing AMR data consortia.

  • Open Access

    AI for Computational Biology: Highlights from the first BioAI Hackathon at University of Warsaw

    by Michał Denkiewicz, Rahaf M. Ahmad, Rishika Gupta, Sachin Gadakh, Jędrzej Kubica, Alishba Nadeem, Alicja Małgorzata Olszewska, Federico Rossi, John Adedeji, Abolhassan Bahari, et al.

    The BioAI Hackathon at the Centre of New Technologies at the University of Warsaw convened 43 international researchers to collaboratively explore artificial intelligence (AI) approaches for solving complex challenges in computational biology. Nine interdisciplinary and multi-institutional teams addressed the following problems: disease-gene prioritization, microbiome analysis, drug-protein interactions, alternative splicing prediction, chromatin architecture study and toxicological profiling. Using cutting-edge tools such as graph neural networks (GNNs), large language models (LLMs), and multi-omics integration frameworks, participants developed scalable and reproducible analytical pipelines. The results include: a disease gene prioritization framework using GNNs, a microbiome dynamics analysis for poultry health prediction and the construction of chromatin structure-aware regulatory networks. All projects follow the open science principles and display translational potential. This hackathon underscores the transformative role of AI in biomedicine and the value of collaborative, time-bounded innovation for accelerating discovery in life sciences. All projects are publicly available on GitHub: https://github.com/SFGLab